Angioscopically apparent large thrombus and uncovered stent struts 6 months after late stent thrombosis of a paclitaxel-coated nitinol drug-eluting stent implanted in the superficial femoral artery

Cardiovascular Intervention and Therapeutics

Volumn 29, Issue 1, 2014, Pages 82-85

  Ishihara, Takayuki ^a   Iida, Osamu ^a   Awata, Masaki ^a   Shiraki, Tatsuya ^a   Nanto, Shinsuke ^b   Uematsu, Masaaki ^a  

^a KANSAI ROSAI HOSPITAL   (Japan)

^b OSAKA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

Angioscopy; Late stent thrombosis; Superficial femoral artery; Zilver PTX

Indexed keywords

ACETYLSALICYLIC ACID; CLOPIDOGREL; HEMOGLOBIN; HEPARIN; PACLITAXEL; UNCLASSIFIED DRUG; UROKINASE; ZILVER PTX;

ANEMIA; ANGIOGRAPHY; ANGIOSCOPE; ARTERY CATHETER; ARTERY CATHETERIZATION; ARTICLE; ASPIRATION CATHETER; BALLOON CATHETER; BARE METAL STENT; BLOOD CLOT LYSIS; CASE REPORT; CLAUDICATION; DISEASE SEVERITY; DRUG WITHDRAWAL; FEMALE; FOLLOW UP; GUIDING CATHETER; HEMARTHROSIS; HEMOGLOBIN BLOOD LEVEL; HUMAN; IN-STENT RESTENOSIS; INTRAVASCULAR ULTRASOUND; INTRAVASCULAR ULTRASOUND SYSTEM; NITINOL STENT; PAIN; PRIORITY JOURNAL; STENT THROMBOSIS; SUPERFICIAL FEMORAL ARTERY; THROMBUS ASPIRATION; VASCULAR GUIDE WIRE;

AGED; ALLOYS; ANGIOGRAPHY; ANGIOSCOPY; ANTINEOPLASTIC AGENTS, PHYTOGENIC; DRUG-ELUTING STENTS; FEMALE; FEMORAL ARTERY; FOLLOW-UP STUDIES; GRAFT OCCLUSION, VASCULAR; HUMANS; INTERMITTENT CLAUDICATION; PACLITAXEL; PROSTHESIS FAILURE; THROMBOSIS; TIME FACTORS;

EID: 84892880036     PISSN: 18684300     EISSN: 18684297     Source Type: Journal    
DOI: 10.1007/s12928-013-0197-5     Document Type: Article

References (8)

1. Soga Y, Tomoi Y, Sato K, Iida O, Yokoi H. Clinical outcome after endovascular treatment for isolated common femoral and popliteal artery disease. Cardiovasc Interv Ther. 2013. (Epub ahead of print).
2. Dohi T, Iida O, Okamoto S, Nanto K, Nanto S, Uematsu M. Mid-term clinical outcome following endovascular therapy in patients with chronic aortic occlusion. Cardiovasc Interv Ther. 2013. (Epub ahead of print).
3. Dake MD, Ansel GM, Jaff MR, Ohki T, Saxon RR, Smouse HB, et al. Paclitaxel-eluting stents show superiority to balloon angioplasty and bare metal stents in femoropopliteal disease: twelve-month Zilver PTX randomized study results. Circ Cardiovasc Interv. 2011;4: 495-504.
4. Dake MD, Scheinert D, Tepe G, Tessarek J, Fanelli F, Bosiers M, et al. Nitinol stents with polymer-free paclitaxel coating for lesions in the superficial femoral and popliteal arteries above the knee: twelve-month safety and effectiveness results from the Zilver PTX single-arm clinical study. J Endovasc Ther. 2011;18: 613-23.
5. Schillinger M, Sabeti S, Loewe C, Dick P, Amighi J, Mlekusch W, et al. Balloon angioplasty versus implantation of nitinol stents in the superficial femoral artery. N Engl J Med. 2006;354: 1879-88.
6. Kimura T, Morimoto T, Nakagawa Y, Tamura T, Kadota K, Yasumoto H, et al. Antiplatelet therapy and stent thrombosis after sirolimus-eluting stent implantation. Circulation. 2009;119: 987-95.
7. Kuchulakanti PK, Chu WW, Torguson R, Ohlmann P, Rha SW, Clavijo LC, et al. Correlates and long-term outcomes of angiographically proven stent thrombosis with sirolimus- and paclitaxel-eluting stents. Circulation. 2006;113: 1108-13.
8. Ishihara T, Iida O, Awata M, Nanto K, Nanto S, Uematsu M. Angioscopic assessment of early phase arterial repair after paclitaxel-coated nitinol drug-eluting stent implantation in the superficial femoral artery. Circ J. 2013. (Epub ahead of print).